Michael Wakelam
 | This article needs additional citations for verification. (April 2020) |
Michael Wakelam | |
|---|---|
| Born | 1955 |
| Died | 31 March 2020 |
| Nationality | British |
| Scientific career | |
| Fields | biochemistry, lipidomics, signal transduction |
| Institutions | Babraham Institute |
Michael J. O. Wakelam (1955 – 31 March 2020) was a British molecular biologist, director of the Babraham Institute in Cambridge, England.
Biography
Wakelam received a BSc in medical biochemistry (1977) and a PhD in biochemistry (1980) from the University of Birmingham. After post-doctoral training at the University of Konstanz (DE), he joined the Department of Biochemistry of Imperial College London in 1983. In 1985, he joined the Biochemistry department of the University of Glasgow as a Lecturer (1985), Senior Lecturer (1991) and Reader (1992). He became a Professor of molecular pharmacology at the University of Birmingham in 1993. In 2007, he became director of the Babraham Institute in Cambridge.[1]
Wakelam died on 31 March 2020 of a suspected COVID-19 infection.[2]
References
- ^ "Michael Wakelam 1955 – 2020 | Babraham Institute". www.babraham.ac.uk. Retrieved 2 April 2020.
- ^ Babraham Institute director Professor Michael Wakelam dies after suspected coronavirus infection
External links
.svg){kind=small}
| International | |
|---|---|
| National | |
| Academics | |
| Other | |
 | This article about a biologist from the United Kingdom is a stub. You can help Wikipedia by expanding it. |
 | This article about the COVID-19 pandemic is a stub. You can help Wikipedia by expanding it. |
- Academics of the University of Cambridge
- British molecular biologists
- Alumni of the University of Birmingham
- 2020 deaths
- 1955 births
- Academics of the University of Glasgow
- Academics of the University of Birmingham
- Deaths from the 2020 coronavirus pandemic in the United Kingdom
- British biologist stubs
- COVID-19 pandemic stubs